Published research exists for ingredients in this formula — see Related research below. Whether this product’s doses match those studies could not be confirmed.

Nugenix Total-T2
Checked against public sources on July 25, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
Category context: sexual-enhancement products carry documented FDA risk This is category history, not proof about this product, but it changes how much unsupported claims deserve to be trusted.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
The checks, one by one
The public sources did not settle the marketing promises on this label.
◐Partly confirmed1
Ingredient research can support context, but it is not a trial of this exact product.
?Couldn’t verify independently1
“Made in USA” can describe only final bottling. Ingredient-sourcing records were not located for this product.
We looked and found no public proof. That does not count against the product.
What is worth knowing.
Headlines first. Open evidence only when you want the source trail.
Category context: sexual-enhancement products carry documented FDA risk
This is category history, not proof about this product, but it changes how much unsupported claims deserve to be trusted.
Evidence and sources
FDA's health-fraud program documents sexual-enhancement products as the most common supplement category found to contain undeclared prescription-drug ingredients. This is a category-level documented fact from FDA's public database — not a test result for this specific product. So…
Locked evidence record →Open the full source-linked findingReviews grew steadily — about 137 between January 29, 2026 to July 22, 2026, with no sudden spike.
Gradual growth is more ordinary. A sudden burst deserves a closer look.
Evidence and sources
Written reviews grew from 81 to 205 across 2026-02-08 – 2026-07-22 with no single manufactured spike (largest 30-day gain ~30).
Locked evidence record →Open the full source-linked findingWhat remains open 2
- No matched to this exact product public label filing is saved in this record.
- Barcode checksum is valid; no independent product record was found.
These are evidence gaps, not strikes against the product.
Filed address
615 S. College St. #1300, Charlotte, NORTH CAROLINA 28202, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
Dose and research context
The label amount is shown beside the ranges used in the linked ingredient studies.
Price check for this exact product
Amazon
Exact UPC/GTIN match$2.67 per labeled serving
matching UPC/GTIN · checked Jul 25, 2026
View on Amazon ↗iHerb
Not confirmedSearch results remain not linked to this exact product until this retailer publishes the matching UPC/GTIN.
Search iHerb ↗Target
Not confirmedSearch results remain not linked to this exact product until this retailer publishes the matching UPC/GTIN.
Search Target ↗Walmart
Not confirmedSearch results remain not linked to this exact product until this retailer publishes the matching UPC/GTIN.
Search Walmart ↗Only one exact price was available at build time; prices change by date, seller, and promotion.
No official brand storefront is confirmed in this record. That is neutral, but it prevents a direct brand-price, label, review, and document check.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
Want the complete evidence trail?
The summary stops at product-specific facts. The full report preserves every source, calculation, limitation, and unresolved check for review or sharing.
Record built July 25, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.